Literature DB >> 27544870

Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging.

Jonathan H Soslow1, Meng Xu2, James C Slaughter2, Michael Stanley3, Kimberly Crum3, Larry W Markham3, David A Parra3.   

Abstract

BACKGROUND: Patients with Duchenne muscular dystrophy (DMD) require frequent imaging to assess left ventricular (LV) function. Poor imaging windows can limit the diagnostic utility of echocardiography. Cardiac magnetic resonance imaging (CMR) is the gold standard for the assessment of LV function but has not been universally adopted in patients with DMD. The study objectives were (1) to evaluate the reproducibility of echocardiographic measures of LV function, (2) to evaluate which echocardiographic methods correlate best with CMR LV ejection fraction (LVEF), and (3) to evaluate whether CMR provides additional value compared with echocardiography.
METHODS: Twenty-eight participants with DMD prospectively underwent echocardiography and CMR. Two blinded readers measured fractional shortening from M-mode and two-dimensional images and LVEF using four-chamber, biplane Simpson, 5/6 area-length, and three-dimensional methods. Speckle-tracking echocardiography was used to analyze circumferential strain. Readers subjectively rated function and segmental wall motion. Agreement was assessed using intraclass correlation coefficients, Bland-Altman plots, Spearman correlation, and weighted κ.
RESULTS: Two-dimensional fractional shortening and 5/6 area-length LVEF had the best combination of reproducibility and correlation with CMR LVEF, though both misclassified approximately 20% as either normal or abnormal function. Other measures of LV function were less reproducible, with worse correlations with CMR LVEF. Thirty-seven percent of segments not visible on echocardiography were believed to have wall motion abnormalities by CMR.
CONCLUSIONS: Two-dimensional fractional shortening and 5/6 area-length LVEF represent the most accurate and reproducible echocardiographic measures of LV function in patients with DMD. CMR should be considered when neither of these techniques is measurable or when it is necessary to detect more subtle cardiovascular changes.
Copyright © 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Cardiomyopathy; Duchenne muscular dystrophy; Echocardiography; Left ventricular dysfunction

Mesh:

Year:  2016        PMID: 27544870      PMCID: PMC5055428          DOI: 10.1016/j.echo.2016.07.001

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  22 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Comparison of left ventricular volumes and ejection fraction by monoplane cineventriculography, unenhanced echocardiography and cardiac magnetic resonance imaging.

Authors:  Chunjian Li; Dirk Lossnitzer; Hugo A Katus; Sebastian J Buss
Journal:  Int J Cardiovasc Imaging       Date:  2011-07-27       Impact factor: 2.357

Review 4.  Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.

Authors:  Christopher F Spurney
Journal:  Muscle Nerve       Date:  2011-07       Impact factor: 3.217

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 6.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

8.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

9.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

10.  Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings.

Authors:  Blake I Gardner; Scott E Bingham; Marvin R Allen; Duane D Blatter; Jeffrey L Anderson
Journal:  Cardiovasc Ultrasound       Date:  2009-08-18       Impact factor: 2.062

View more
  21 in total

1.  Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.

Authors:  Bryan Siegel; Laura Olivieri; Heather Gordish-Dressman; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

2.  When Ejection Fraction Is Not Enough: The Search for Early Signs of Cardiomyopathy in Duchenne Muscular Dystrophy.

Authors:  Pierangelo Renella; Wyman W Lai
Journal:  Circ Cardiovasc Imaging       Date:  2020-11-16       Impact factor: 7.792

Review 3.  Multi-modal imaging of the pediatric heart transplant recipient.

Authors:  Jonathan H Soslow; Margaret M Samyn
Journal:  Transl Pediatr       Date:  2019-10

4.  Troponin I Levels Correlate with Cardiac MR LGE and Native T1 Values in Duchenne Muscular Dystrophy Cardiomyopathy and Identify Early Disease Progression.

Authors:  Sonia Voleti; Laura Olivieri; Karin Hamann; Heather Gordish-Dressman; Christopher Spurney
Journal:  Pediatr Cardiol       Date:  2020-05-31       Impact factor: 1.655

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.

Authors:  Sean M Lang; Tarek Alsaied; Philip R Khoury; Thomas D Ryan; Michael D Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-20       Impact factor: 2.357

8.  Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.

Authors:  John P Bourke; Teofila Bueser; Rosaline Quinlivan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16

9.  Echocardiographic Image Quality Deteriorates with Age in Children and Young Adults with Duchenne Muscular Dystrophy.

Authors:  Alyssa Power; Sabrina Poonja; Dal Disler; Kimberley Myers; David J Patton; Jean K Mah; Nowell M Fine; Steven C Greenway
Journal:  Front Cardiovasc Med       Date:  2017-12-20

10.  Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.

Authors:  Sarka Jelinkova; Yvonne Sleiman; Petr Fojtík; Franck Aimond; Amanda Finan; Gerald Hugon; Valerie Scheuermann; Deborah Beckerová; Olivier Cazorla; Marie Vincenti; Pascal Amedro; Sylvain Richard; Josef Jaros; Petr Dvorak; Alain Lacampagne; Gilles Carnac; Vladimir Rotrekl; Albano C Meli
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.